© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
November 04, 2020
A new study finds patients with sickle cell disease are moderately adherent to hydroxyurea.
October 12, 2020
NASH and NAFLD are notoriously difficult to treat conditions.
October 07, 2020
Paul Christo, MD, discusses opioid addiction during the pandemic, the role of the clinician, and offers a hopeful outlook for the future.
October 05, 2020
An expert discusses steps the FDA can take to strengthen and make more airtight their process for approving new opioids.
October 02, 2020
An expert discusses the effect the pandemic has had on opioid use and related deaths.
Dr. Moon says new strategies must be implemented to help NAFLD patients deal with pain.
Higher levels of acetaminophen detected in meconium was linked to increased odds of developing ADHD by 6-7 years old.
October 01, 2020
A pharmacoepidemiologist offers his comments on the ongoing opioid epidemic.
September 29, 2020
A new cross-sectional study uncovers shortcomings in pivotal trials supporting new drug applications for opioid analgesics, which range from study design to duration.
As part of the TARGET-NASH study, researchers find 18% of NAFLD patients are prescribed opioids because of pain.